- SGX Pharmaceuticals Announces Strategic Collaboration To Develop And Commercialize BCR-ABL Inhibitor
- UP and Down, Up and Down
- Best Diet – 3 Key Features Your Diet MUST Have For Weight Loss Success
- Commercial Pet Foods: The Best Food for Pets
- Some Simple Tips To Help You Eat Healthier
- Ontario Is A Fishing Paradise
- Benefits of Searching For People Online
- Self-Esteem and Getting Organized are Inseparable
- Control Your Business With POS Software
- Forex: Professional Market Investor Reveals A Short-Cut To Mastering Stock Market Investing Rules
sgx
SGX Pharmaceuticals Announces Strategic Collaboration To Develop And Commercialize BCR-ABL Inhibitor
Under the terms of the agreement, SGX will receive from Novartis $25 million in upfront payments and the purchase of SGX common stock. Along with success-based milestones, but excluding royalties, total payments to SGX could exceed $515 million, including a minimum of two years of research funding. The success of Gleevec(TM) (imatinib), the first targeted [...]